Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1980 1
1985 1
1986 2
1987 3
1988 5
1989 2
1990 7
1991 6
1992 4
1993 11
1994 11
1995 5
1996 4
1997 4
1998 5
1999 6
2000 2
2001 3
2002 6
2003 8
2004 6
2005 8
2007 7
2008 5
2009 6
2010 4
2011 8
2012 9
2013 7
2014 9
2015 8
2016 9
2017 7
2018 11
2019 7
2020 8
2021 11
2022 14
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

229 results

Results by year

Filters applied: . Clear all
Page 1
Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.
Tsang RW, Campbell BA, Goda JS, Kelsey CR, Kirova YM, Parikh RR, Ng AK, Ricardi U, Suh CO, Mauch PM, Specht L, Yahalom J. Tsang RW, et al. Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):794-808. doi: 10.1016/j.ijrobp.2018.05.009. Epub 2018 Jun 20. Int J Radiat Oncol Biol Phys. 2018. PMID: 29976492 Review.
In contrast, a small proportion of patients with plasma cell neoplasms present with a localized plasmacytoma in the bone, or in extramedullary (extraosseous) soft tissues, and definitive RT is the standard treatment. RT provides long-term local control in the solita …
In contrast, a small proportion of patients with plasma cell neoplasms present with a localized plasmacytoma in the bone, or in ex
Solitary Plasmacytoma: a Review of Diagnosis and Management.
Pham A, Mahindra A. Pham A, et al. Curr Hematol Malig Rep. 2019 Apr;14(2):63-69. doi: 10.1007/s11899-019-00499-8. Curr Hematol Malig Rep. 2019. PMID: 30788667 Review.
PURPOSE OF REVIEW: Solitary plasmacytoma is a rare plasma cell dyscrasia, classified as solitary bone plasmacytoma or solitary extramedullary plasmacytoma. ...While the treatment paradigm for solitary plasmacytoma has not changed significantly o …
PURPOSE OF REVIEW: Solitary plasmacytoma is a rare plasma cell dyscrasia, classified as solitary bone plasmacytoma or solitary …
Extramedullary disease in multiple myeloma: a systematic literature review.
Bladé J, Beksac M, Caers J, Jurczyszyn A, von Lilienfeld-Toal M, Moreau P, Rasche L, Rosiñol L, Usmani SZ, Zamagni E, Richardson P. Bladé J, et al. Blood Cancer J. 2022 Mar 21;12(3):45. doi: 10.1038/s41408-022-00643-3. Blood Cancer J. 2022. PMID: 35314675 Free PMC article. Review.
Extramedullary involvement (or extramedullary disease, EMD) represents an aggressive form of multiple myeloma (MM), characterized by the ability of a clone and/or subclone to thrive and grow independent of the bone marrow microenvironment. ...Available data demonstr
Extramedullary involvement (or extramedullary disease, EMD) represents an aggressive form of multiple myeloma (MM), characteri
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel.
Caers J, Paiva B, Zamagni E, Leleu X, Bladé J, Kristinsson SY, Touzeau C, Abildgaard N, Terpos E, Heusschen R, Ocio E, Delforge M, Sezer O, Beksac M, Ludwig H, Merlini G, Moreau P, Zweegman S, Engelhardt M, Rosiñol L. Caers J, et al. J Hematol Oncol. 2018 Jan 16;11(1):10. doi: 10.1186/s13045-017-0549-1. J Hematol Oncol. 2018. PMID: 29338789 Free PMC article. Review.
Solitary plasmacytoma is an infrequent form of plasma cell dyscrasia that presents as a single mass of monoclonal plasma cells, located either extramedullary or intraosseous. ...In this review, a panel of expert European hematologists updates the recommendations on …
Solitary plasmacytoma is an infrequent form of plasma cell dyscrasia that presents as a single mass of monoclonal plasma cells, locat …
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
Rosiñol L, Beksac M, Zamagni E, Van de Donk NWCJ, Anderson KC, Badros A, Caers J, Cavo M, Dimopoulos MA, Dispenzieri A, Einsele H, Engelhardt M, Fernández de Larrea C, Gahrton G, Gay F, Hájek R, Hungria V, Jurczyszyn A, Kröger N, Kyle RA, Leal da Costa F, Leleu X, Lentzsch S, Mateos MV, Merlini G, Mohty M, Moreau P, Rasche L, Reece D, Sezer O, Sonneveld P, Usmani SZ, Vanderkerken K, Vesole DH, Waage A, Zweegman S, Richardson PG, Bladé J. Rosiñol L, et al. Br J Haematol. 2021 Aug;194(3):496-507. doi: 10.1111/bjh.17338. Epub 2021 Mar 16. Br J Haematol. 2021. PMID: 33724461 Free article. Review.
In this review, two types of soft-tissue involvement in multiple myeloma are defined: (i) extramedullary (EMD) with haematogenous spread involving only soft tissues and (ii) paraskeletal (PS) with tumour masses arising from skeletal lesions. The incidence of EMD and PS …
In this review, two types of soft-tissue involvement in multiple myeloma are defined: (i) extramedullary (EMD) with haematogenous spr …
Extramedullary Plasmacytoma: Long-Term Clinical Outcomes in a Single-Center in China and Literature Review.
Zhu X, Wang L, Zhu Y, Diao W, Li W, Gao Z, Chen X. Zhu X, et al. Ear Nose Throat J. 2021 May;100(4):227-232. doi: 10.1177/0145561320950587. Epub 2020 Sep 17. Ear Nose Throat J. 2021. PMID: 32941076 Free article. Review.
The aim is to analyze the clinical outcomes of patients with extramedullary plasmacytoma (EMP) and review the characteristics of this disease. ...Previous major cohort studies were reviewed and compared with this study. Extramedullary plasmacytomas wer …
The aim is to analyze the clinical outcomes of patients with extramedullary plasmacytoma (EMP) and review the characteristics …
Retroperitoneal extramedullary plasmacytoma: A case report and review of the literature.
Wang J, Li J, Zhang F, Zhang P. Wang J, et al. Medicine (Baltimore). 2018 Nov;97(46):e13281. doi: 10.1097/MD.0000000000013281. Medicine (Baltimore). 2018. PMID: 30431616 Free PMC article. Review.
RATIONALE: The incidence of extramedullary plasmacytoma (EMP) accounts for 3% to 4% of all cases of generalized plasmacytoma. ...LESSONS: Retroperitoneal extramedullary plasmacytoma (EMP) is a rare condition that is frequently a diagnostic chall …
RATIONALE: The incidence of extramedullary plasmacytoma (EMP) accounts for 3% to 4% of all cases of generalized plasmacytom
Extramedullary Plasmacytoma of Nasal Cavity: A Case Report and Literature Review.
Hu X, Peng C, Wang P, Cai J. Hu X, et al. Ear Nose Throat J. 2022 Jul;101(6):NP245-NP250. doi: 10.1177/0145561320960005. Epub 2020 Oct 12. Ear Nose Throat J. 2022. PMID: 33044842 Free article. Review.
Extramedullary plasmacytoma (EMP) is a tumor characterized by plasma cell proliferation in organs or tissues outside the bone marrow. It originates from B lymphocytes and can occur in all extramedullary tissues and organs of the body. Primary EMPs of the nasa
Extramedullary plasmacytoma (EMP) is a tumor characterized by plasma cell proliferation in organs or tissues outside the bone
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group.
Cavo M, Terpos E, Nanni C, Moreau P, Lentzsch S, Zweegman S, Hillengass J, Engelhardt M, Usmani SZ, Vesole DH, San-Miguel J, Kumar SK, Richardson PG, Mikhael JR, da Costa FL, Dimopoulos MA, Zingaretti C, Abildgaard N, Goldschmidt H, Orlowski RZ, Chng WJ, Einsele H, Lonial S, Barlogie B, Anderson KC, Rajkumar SV, Durie BGM, Zamagni E. Cavo M, et al. Lancet Oncol. 2017 Apr;18(4):e206-e217. doi: 10.1016/S1470-2045(17)30189-4. Lancet Oncol. 2017. PMID: 28368259 Review.
The International Myeloma Working Group consensus aimed to provide recommendations for the optimal use of (18)fluorodeoxyglucose ((18)F-FDG) PET/CT in patients with multiple myeloma and other plasma cell disorders, including smouldering multiple myeloma and solitary plasmacyto
The International Myeloma Working Group consensus aimed to provide recommendations for the optimal use of (18)fluorodeoxyglucose ((18)F-FDG) …
Extramedullary plasmacytoma: Tumor occurrence and therapeutic concepts-A follow-up.
Holler A, Cicha I, Eckstein M, Haderlein M, Pöttler M, Rappl A, Iro H, Alexiou C. Holler A, et al. Cancer Med. 2022 Dec;11(24):4743-4755. doi: 10.1002/cam4.4816. Epub 2022 May 16. Cancer Med. 2022. PMID: 35578404 Free PMC article. Review.
BACKGROUND: Extramedullary plasmacytoma (EMP) is a solitary tumor consisting of neoplastic plasma cells, with very little to no bone marrow involvement. ...
BACKGROUND: Extramedullary plasmacytoma (EMP) is a solitary tumor consisting of neoplastic plasma cells, with very little to n …
229 results